Bivin & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Bivin & Associates's JNJ Position: Q2 2022 in Review
Bivin & Associates reduced its Johnson & Johnson (JNJ) stake by 12% in Q2 2022, selling an estimated $155K and leaving 6,162 shares worth $1.09M. The position accounts for 1.18% of the portfolio, ranked #16.
Bivin & Associates first reported a position in JNJ in Q4 2021 and has held it in 3 quarters since. The position peaked at $1.27M in Q4 2021. 3,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2022.
- Bivin & Associates held 6,162 shares of Johnson & Johnson worth $1.09M as of Q2 2022.
- Bivin & Associates sold 872 Johnson & Johnson shares in Q2 2022, an estimated $155K.
- Johnson & Johnson made up 1.18% of Bivin & Associates's portfolio in Q2 2022, its #16 holding.
- Bivin & Associates first reported a position in Johnson & Johnson in Q4 2021 and has held it in 3 quarters since.
- Bivin & Associates's Johnson & Johnson position peaked at $1.27M in Q4 2021.
- 3,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2022.
Based on Bivin & Associates's 13F filing for Q2 2022, filed 11 Aug 2022.